Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000428 | DNA-directed RNA polymerase complex | 4 | 12 |
GO:0030880 | RNA polymerase complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 12 |
GO:0140535 | intracellular protein-containing complex | 2 | 12 |
GO:1902494 | catalytic complex | 2 | 12 |
GO:1990234 | transferase complex | 3 | 12 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005658 | alpha DNA polymerase:primase complex | 4 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0042575 | DNA polymerase complex | 3 | 1 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7WWZ8
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006269 | DNA replication, synthesis of RNA primer | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009058 | biosynthetic process | 2 | 1 |
GO:0009059 | macromolecule biosynthetic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0018130 | heterocycle biosynthetic process | 4 | 1 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 1 |
GO:0032774 | RNA biosynthetic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044249 | cellular biosynthetic process | 3 | 1 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 1 |
GO:1901576 | organic substance biosynthetic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0003896 | DNA primase activity | 7 | 12 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 6 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 12 |
GO:0016779 | nucleotidyltransferase activity | 4 | 12 |
GO:0034062 | 5'-3' RNA polymerase activity | 5 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0097747 | RNA polymerase activity | 4 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 291 | 295 | PF00656 | 0.312 |
CLV_C14_Caspase3-7 | 403 | 407 | PF00656 | 0.438 |
CLV_C14_Caspase3-7 | 55 | 59 | PF00656 | 0.741 |
CLV_C14_Caspase3-7 | 85 | 89 | PF00656 | 0.670 |
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.276 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.240 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.240 |
CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.240 |
CLV_NRD_NRD_1 | 321 | 323 | PF00675 | 0.241 |
CLV_NRD_NRD_1 | 378 | 380 | PF00675 | 0.255 |
CLV_PCSK_FUR_1 | 230 | 234 | PF00082 | 0.242 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.261 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.240 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.240 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.240 |
CLV_PCSK_KEX2_1 | 321 | 323 | PF00082 | 0.255 |
CLV_PCSK_KEX2_1 | 378 | 380 | PF00082 | 0.255 |
CLV_PCSK_SKI1_1 | 210 | 214 | PF00082 | 0.274 |
CLV_PCSK_SKI1_1 | 232 | 236 | PF00082 | 0.275 |
CLV_PCSK_SKI1_1 | 239 | 243 | PF00082 | 0.232 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.315 |
CLV_PCSK_SKI1_1 | 282 | 286 | PF00082 | 0.251 |
CLV_PCSK_SKI1_1 | 322 | 326 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 436 | 440 | PF00082 | 0.380 |
CLV_Separin_Metazoa | 128 | 132 | PF03568 | 0.457 |
DEG_APCC_DBOX_1 | 378 | 386 | PF00400 | 0.240 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.523 |
DEG_SPOP_SBC_1 | 289 | 293 | PF00917 | 0.312 |
DOC_CDC14_PxL_1 | 365 | 373 | PF14671 | 0.240 |
DOC_CYCLIN_RxL_1 | 158 | 168 | PF00134 | 0.269 |
DOC_CYCLIN_yCln2_LP_2 | 383 | 389 | PF00134 | 0.240 |
DOC_MAPK_gen_1 | 219 | 226 | PF00069 | 0.240 |
DOC_MAPK_gen_1 | 378 | 385 | PF00069 | 0.255 |
DOC_MAPK_HePTP_8 | 375 | 387 | PF00069 | 0.255 |
DOC_MAPK_MEF2A_6 | 219 | 226 | PF00069 | 0.240 |
DOC_MAPK_MEF2A_6 | 378 | 387 | PF00069 | 0.241 |
DOC_MAPK_NFAT4_5 | 219 | 227 | PF00069 | 0.240 |
DOC_MAPK_RevD_3 | 364 | 379 | PF00069 | 0.255 |
DOC_PP1_RVXF_1 | 159 | 166 | PF00149 | 0.266 |
DOC_PP2B_LxvP_1 | 383 | 386 | PF13499 | 0.240 |
DOC_USP7_MATH_1 | 190 | 194 | PF00917 | 0.334 |
DOC_USP7_MATH_1 | 290 | 294 | PF00917 | 0.245 |
DOC_USP7_MATH_1 | 348 | 352 | PF00917 | 0.384 |
DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.692 |
DOC_WD40_RPTOR_TOS_1 | 165 | 171 | PF00400 | 0.240 |
LIG_14-3-3_CanoR_1 | 115 | 120 | PF00244 | 0.312 |
LIG_14-3-3_CanoR_1 | 282 | 289 | PF00244 | 0.353 |
LIG_14-3-3_CanoR_1 | 29 | 33 | PF00244 | 0.541 |
LIG_14-3-3_CanoR_1 | 34 | 41 | PF00244 | 0.632 |
LIG_14-3-3_CanoR_1 | 429 | 433 | PF00244 | 0.337 |
LIG_Actin_WH2_1 | 239 | 257 | PF00022 | 0.384 |
LIG_Actin_WH2_2 | 242 | 257 | PF00022 | 0.384 |
LIG_deltaCOP1_diTrp_1 | 401 | 408 | PF00928 | 0.342 |
LIG_EH1_1 | 359 | 367 | PF00400 | 0.384 |
LIG_FHA_1 | 21 | 27 | PF00498 | 0.336 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.305 |
LIG_FHA_1 | 311 | 317 | PF00498 | 0.375 |
LIG_FHA_1 | 354 | 360 | PF00498 | 0.364 |
LIG_FHA_1 | 391 | 397 | PF00498 | 0.240 |
LIG_FHA_1 | 429 | 435 | PF00498 | 0.459 |
LIG_FHA_2 | 233 | 239 | PF00498 | 0.334 |
LIG_FHA_2 | 276 | 282 | PF00498 | 0.310 |
LIG_FHA_2 | 375 | 381 | PF00498 | 0.240 |
LIG_FHA_2 | 441 | 447 | PF00498 | 0.582 |
LIG_LIR_Apic_2 | 427 | 433 | PF02991 | 0.301 |
LIG_LIR_Gen_1 | 103 | 113 | PF02991 | 0.289 |
LIG_LIR_Gen_1 | 11 | 21 | PF02991 | 0.302 |
LIG_LIR_Gen_1 | 186 | 196 | PF02991 | 0.313 |
LIG_LIR_Gen_1 | 281 | 290 | PF02991 | 0.233 |
LIG_LIR_Gen_1 | 401 | 410 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 103 | 109 | PF02991 | 0.261 |
LIG_LIR_Nem_3 | 11 | 16 | PF02991 | 0.311 |
LIG_LIR_Nem_3 | 111 | 116 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 206 | 212 | PF02991 | 0.243 |
LIG_LIR_Nem_3 | 23 | 28 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 281 | 287 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 341 | 345 | PF02991 | 0.240 |
LIG_LIR_Nem_3 | 401 | 405 | PF02991 | 0.336 |
LIG_LYPXL_S_1 | 367 | 371 | PF13949 | 0.240 |
LIG_LYPXL_yS_3 | 368 | 371 | PF13949 | 0.240 |
LIG_NRBOX | 198 | 204 | PF00104 | 0.184 |
LIG_Pex14_2 | 284 | 288 | PF04695 | 0.240 |
LIG_SH2_CRK | 172 | 176 | PF00017 | 0.255 |
LIG_SH2_GRB2like | 172 | 175 | PF00017 | 0.334 |
LIG_SH2_NCK_1 | 13 | 17 | PF00017 | 0.426 |
LIG_SH2_PTP2 | 211 | 214 | PF00017 | 0.274 |
LIG_SH2_SRC | 13 | 16 | PF00017 | 0.383 |
LIG_SH2_SRC | 172 | 175 | PF00017 | 0.334 |
LIG_SH2_STAP1 | 13 | 17 | PF00017 | 0.297 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.287 |
LIG_SH2_STAT5 | 211 | 214 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 245 | 248 | PF00017 | 0.255 |
LIG_SH2_STAT5 | 307 | 310 | PF00017 | 0.265 |
LIG_SH2_STAT5 | 345 | 348 | PF00017 | 0.260 |
LIG_SH2_STAT5 | 98 | 101 | PF00017 | 0.315 |
LIG_SH3_3 | 245 | 251 | PF00018 | 0.241 |
LIG_SUMO_SIM_par_1 | 17 | 23 | PF11976 | 0.302 |
LIG_TRAF2_1 | 121 | 124 | PF00917 | 0.444 |
LIG_TRAF2_1 | 351 | 354 | PF00917 | 0.375 |
LIG_TRAF2_1 | 52 | 55 | PF00917 | 0.537 |
LIG_TYR_ITIM | 243 | 248 | PF00017 | 0.240 |
LIG_TYR_ITIM | 366 | 371 | PF00017 | 0.240 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.293 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.263 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.661 |
MOD_CK2_1 | 118 | 124 | PF00069 | 0.293 |
MOD_CK2_1 | 232 | 238 | PF00069 | 0.366 |
MOD_CK2_1 | 348 | 354 | PF00069 | 0.384 |
MOD_CK2_1 | 49 | 55 | PF00069 | 0.657 |
MOD_CK2_1 | 5 | 11 | PF00069 | 0.380 |
MOD_Cter_Amidation | 217 | 220 | PF01082 | 0.240 |
MOD_Cter_Amidation | 319 | 322 | PF01082 | 0.384 |
MOD_GlcNHglycan | 120 | 123 | PF01048 | 0.314 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.251 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.240 |
MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.258 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.532 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.581 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.637 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.328 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.367 |
MOD_GSK3_1 | 250 | 257 | PF00069 | 0.297 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.547 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.535 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.265 |
MOD_NEK2_1 | 254 | 259 | PF00069 | 0.384 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.273 |
MOD_NEK2_1 | 420 | 425 | PF00069 | 0.388 |
MOD_OFUCOSY | 188 | 194 | PF10250 | 0.299 |
MOD_PIKK_1 | 20 | 26 | PF00454 | 0.332 |
MOD_PIKK_1 | 275 | 281 | PF00454 | 0.384 |
MOD_PIKK_1 | 28 | 34 | PF00454 | 0.264 |
MOD_PKA_1 | 232 | 238 | PF00069 | 0.354 |
MOD_PKA_2 | 232 | 238 | PF00069 | 0.242 |
MOD_PKA_2 | 254 | 260 | PF00069 | 0.384 |
MOD_PKA_2 | 28 | 34 | PF00069 | 0.517 |
MOD_PKA_2 | 428 | 434 | PF00069 | 0.487 |
MOD_PKB_1 | 230 | 238 | PF00069 | 0.334 |
MOD_Plk_1 | 237 | 243 | PF00069 | 0.245 |
MOD_Plk_1 | 46 | 52 | PF00069 | 0.733 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.356 |
MOD_Plk_4 | 198 | 204 | PF00069 | 0.380 |
MOD_Plk_4 | 244 | 250 | PF00069 | 0.247 |
MOD_Plk_4 | 254 | 260 | PF00069 | 0.278 |
MOD_Plk_4 | 341 | 347 | PF00069 | 0.296 |
MOD_SUMO_for_1 | 44 | 47 | PF00179 | 0.609 |
MOD_SUMO_for_1 | 66 | 69 | PF00179 | 0.540 |
MOD_SUMO_rev_2 | 82 | 92 | PF00179 | 0.526 |
TRG_AP2beta_CARGO_1 | 111 | 120 | PF09066 | 0.445 |
TRG_DiLeu_BaEn_1 | 238 | 243 | PF01217 | 0.274 |
TRG_DiLeu_BaLyEn_6 | 263 | 268 | PF01217 | 0.366 |
TRG_ENDOCYTIC_2 | 13 | 16 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.255 |
TRG_ENDOCYTIC_2 | 245 | 248 | PF00928 | 0.240 |
TRG_ENDOCYTIC_2 | 368 | 371 | PF00928 | 0.240 |
TRG_ER_diArg_1 | 229 | 232 | PF00400 | 0.384 |
TRG_Pf-PMV_PEXEL_1 | 161 | 166 | PF00026 | 0.258 |
TRG_Pf-PMV_PEXEL_1 | 347 | 352 | PF00026 | 0.245 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDK6 | Leptomonas seymouri | 76% | 100% |
A0A0S4IXR0 | Bodo saltans | 51% | 100% |
A0A1X0NUV3 | Trypanosomatidae | 59% | 100% |
A0A3R7KRU9 | Trypanosoma rangeli | 60% | 100% |
A4HC88 | Leishmania braziliensis | 85% | 100% |
A4HZR7 | Leishmania infantum | 100% | 100% |
C9ZRJ5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 100% |
E9AVM3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
O14215 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 35% | 99% |
P10363 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 33% | 100% |
P20664 | Mus musculus | 35% | 100% |
P34471 | Caenorhabditis elegans | 31% | 100% |
P49642 | Homo sapiens | 34% | 100% |
Q24317 | Drosophila melanogaster | 33% | 100% |
Q25998 | Plasmodium falciparum (isolate K1 / Thailand) | 33% | 100% |
Q4QBV6 | Leishmania major | 96% | 100% |
Q7KQM1 | Plasmodium falciparum (isolate 3D7) | 33% | 100% |
V5AVR1 | Trypanosoma cruzi | 61% | 100% |